Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-23

FDA Approved: EYE ALLERGY RELIEF — Supplemental Application (DOLGENCORP, LLC)

View source ↗

Summary

FDA approved a supplemental application for Eye Allergy Relief (pheniramine maleate and naphazoline hydrochloride) from DolgenCorp, LLC. The product is indicate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)

Snippet

SUPPL AP for EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)